Marsh & McLennan is executing well across broking and consulting, with 2025 revenue of $26.98B and Q1 2026 growth still running at 8%. The stock looks like a quality compounder, but valuation and leverage keep the upside measured.
Marsh & McLennan Companies, Inc. (MRSH) looks like a high-quality compounder rather than a bargain-bin value play. The core case rests on a few hard facts. Revenue reached $26.98B in 2025, up from $24.46B in 2024 and $22.74B in 2023. Operating income rose to $6.22B in 2025 from $5.82B in 2024, while free cash flow climbed to $5.00B from $3.99B. In Q1 2026, revenue increased 8% to $7.6B, adjusted operating income grew 8%, and adjusted EPS reached $3.29 versus $3.22 expected. That is the profile of a business still executing even as insurance pricing softens.
The medium-term appeal is not just size. It is the mix. MRSH combines global insurance broking, reinsurance, employee benefits, wealth advisory, and management consulting under one roof. That diversification matters when one lane slows. In Q1 2026, Risk and Insurance Services posted 3% underlying growth while Consulting delivered 5% underlying growth. Mercer’s assets under management rose to $727B, up 19% from a year earlier, while Marsh Management Consulting grew revenue 10%. The machine has more than one engine.
The main pushback is valuation and leverage. MRSH trades at 22.0x trailing earnings and 17.2x forward earnings, with a PEG ratio of 1.72. Net debt stood at $18.76B at year-end 2025, and total debt was $20.93B at March 31, 2026. That is manageable for a cash-rich advisory platform, but it limits how cheap the stock can reasonably look. This is a stock for moderate-risk investors who want durable execution, recurring cash generation, and steady capital returns, not a stock for investors hunting for a dramatic rerating from a distressed base.
MRSH is a global professional services firm headquartered in New York and founded in 1871. It operates in 130 countries, employs about 95,000 people, and reports through two segments: Risk and Insurance Services and Consulting. The company changed its brand name from Marsh McLennan to Marsh effective January 14, 2026, while renaming the Marsh and Oliver Wyman Group businesses to Marsh Risk and Marsh Management Consulting.
The business model is straightforward in concept and complex in execution. MRSH earns revenue from insurance and reinsurance broking, risk advisory, health and benefits consulting, wealth and investment advisory, and management consulting. Those services generate a blend of recurring advisory fees, placement-related revenue, and cross-sell opportunities across client relationships. In plain English, MRSH gets paid for helping clients navigate risk, people, and strategy problems that are expensive to get wrong.
Scale is central to the story. The investor presentation cites about $193B of annual premiums placed, $727B of AUM as of March 31, 2026, and more than $16.2T of assets under advisement as of June 30, 2025. Those figures help explain why the company can invest in data, AI, and operating infrastructure at a level that smaller rivals struggle to match.
Risk and Insurance Services is the larger segment and the company’s economic backbone. The 2025 Form 10-K says it accounted for about 64% of 2025 revenue and roughly 55,700 colleagues. In Q1 2026, segment revenue was $5.1B, up 6% reported and 3% underlying. Adjusted operating income reached $1.9B, up 7%, and adjusted operating margin improved 10 bps to 38.3%.
Within that segment, Marsh Risk remains the flagship growth driver. Q1 2026 revenue was $3.7B, up 8% reported and 4% underlying. Underlying growth was 3% in the U.S. and Canada and 5% internationally, including 6% in EMEA and 5% in Asia Pacific. That is notable because management also said primary commercial insurance rates fell 5% globally in Q1, with property down 9%. Growing brokerage revenue while pricing falls is a sign that client retention, new business, and advisory depth are doing real work.
Guy Carpenter is smaller but strategically important. Q1 2026 revenue was $1.2B, up 3% reported and 2% underlying. That growth came despite softer reinsurance pricing and rate reductions of 15% to 20% for some non-loss impacted U.S. property catastrophe accounts. In a looser reinsurance market, volume and client relationships matter more, and Guy Carpenter still posted growth.
Consulting is the second pillar and gives MRSH a different earnings texture than pure-play brokers. Q1 2026 Consulting revenue was $2.6B, up 11% reported and 5% underlying. Adjusted operating income rose 13% to $552M, and adjusted operating margin expanded 40 bps to 21.6%. That margin is lower than Risk and Insurance Services, but the segment adds diversification and opens cross-selling doors.
Mercer is the largest consulting business. Q1 2026 revenue was $1.7B, up 11% reported and 5% underlying. Health grew 6%, wealth grew 5%, and career declined 2%. The standout data point is AUM of $727B, up 5% sequentially and 19% from a year earlier. Wealth advisory and investment services bring sticky client relationships and benefit from both new wins and market levels.
Marsh Management Consulting generated $897M of revenue in Q1 2026, up 10% reported and 6% underlying. Management cited solid demand across most regions and sectors. That matters because consulting can be the first business investors worry about in a slower economy. So far, the numbers show resilience rather than retrenchment.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
MRSH does not sell a single consumer product with a neat price tag. Its flagship offerings are platforms, data tools, and advisory workflows embedded inside client service. The named products management highlighted include AIDA, Centrus, EUCLID, GC QuoteBox, Claims IQ, Mercer Fiber, and the Marsh Risk Companion suite. The point is not branding for its own sake. The point is that these tools turn proprietary data and workflow efficiency into client retention and margin support.
Claims IQ stands out because management tied it to measurable scale. Nicholas Studer said several thousand colleagues are using AI-enabled analysis of almost $200B of loss information to improve advice, decision-making, and claims advocacy. In insurance broking, claims support is where the broker proves its worth after the sales pitch is over. A broker that helps clients recover money faster tends to keep the account.
GC QuoteBox is another meaningful example. Dean Klisura described it as an AI-driven document ingestion tool that helps Guy Carpenter process large volumes of unstructured client data and match risk with capital more efficiently. That sounds technical, because it is, but the business implication is simple: faster turnaround, better broker productivity, and potentially better client outcomes in a market where speed matters.
Mercer Fiber shows the same pattern in a different vertical. Patrick Tomlinson said health consultants use it for real-time scenario planning, budget tracking, benchmarking, and plan management using client-specific claims data. That is not generic chatbot theater. It is workflow software attached to advisory relationships and recurring consulting revenue.
Nimbus capacity also deserves mention. The investor presentation describes it as a market-leading, large-scale data center construction insurance facility. The same slide shows global data center capacity rising from 103 GW in 2025 to 200 GW by 2030E, a 14% CAGR. That ties MRSH directly to one of the largest capital-spending themes in the market without needing to own a chip stock to get there.
MRSH’s moat is built on scale, trust, data, and breadth. Management framed its AI strategy around three pillars: growth, productivity, and efficiency. That framework matters because it shows AI is not being treated as a shiny object. It is being used to win more business, help employees do more, and lower operating friction.
The strongest evidence is operational, not rhetorical. John Doyle said document ingestion tools are already handling thousands of documents weekly and improving efficiency in those processes by 20%. He also said AI-enabled tools in pilot areas drove a 50% increase in sales velocity. Those are the kinds of numbers that matter. They suggest AI is moving from slide deck to P&L.
MRSH also benefits from the kind of complexity that resists commoditization. Doyle said the company is not selling commoditized products or simply procuring insurance at the lowest possible price. That is a useful distinction. In complex commercial insurance, reinsurance, benefits, and strategy work, the client is often buying judgment, market access, analytics, and negotiation leverage. AI can sharpen those tools, but it does not erase the need for them.
The acquisition track record adds another layer to the moat. The McGriff acquisition closed in November 2024 for $7.75B in cash and expanded MRSH’s U.S. middle-market brokerage footprint. In an industry where scale tends to attract more scale, that matters. The company also completed 17 acquisitions in 2024, according to industry context, reinforcing its ability to use M&A as a growth lever rather than a rescue plan.
MRSH is a services company, so its operational backbone is talent, data, workflow, and global delivery rather than factories and raw materials. The company’s Business Client Services unit is central to that model. Management said BCS was created to consolidate back-office operations and technology into scalable centers and accelerate AI-driven automation and process reengineering.
The Thrive program is the clearest operating initiative in the current story. Management remains on track to generate $400M of total savings while incurring about $500M of charges to achieve them. In Q1 2026, noteworthy items totaled $521M, including $37M of Thrive-related costs and a $425M litigation charge tied to the Greenfield matter. The savings target matters because MRSH already has a long margin-expansion record. Squeezing more efficiency out of an already efficient model is harder than doing it from a bloated base.
Capital deployment also reflects disciplined operations. In Q1 2026, uses of cash totaled $1.3B, including $440M for dividends, $89M for acquisitions, and $750M for share repurchases. Management expects to deploy about $5B of capital in 2026 across dividends, acquisitions, and buybacks. That is a large number, but it fits a business that produced $5.00B of free cash flow in 2025.
Supply-chain exposure shows up mainly through client demand rather than internal production risk. Doyle said MRSH is helping clients address supply-chain issues, review cyber exposure, and manage risks in marine, aviation, and energy. That is a subtle but important point. Geopolitical and logistics disruptions can create advisory demand for MRSH even when they create headaches elsewhere.
The insurance brokerage market is large and still growing. Third-party estimates in the research context place 2025 global insurance brokerage TAM around $327B to $336B, with forward CAGR near 9% to 10%. That gives MRSH a big runway even as one of the largest players. A giant fish in a very large pond still has room to swim.
Within that market, current pricing conditions are mixed. Management said global primary commercial insurance rates fell 5% in Q1 2026, with property down 9%, financial and professional liability down 5%, and cyber down 5%, while global casualty rates rose 3% and U.S. excess casualty rose 18%. For MRSH, that means some lines are becoming more buyer-friendly, but complexity remains high. Softer pricing can pressure commission growth, yet it can also stimulate placement activity and advisory work as clients redesign programs.
Reinsurance is also in a competitive phase. Management said there is substantial capacity, strong reinsurer profitability, and increased capital levels, leading to ample supply and meaningful rate reductions. Again, that is not ideal for a simple volume-times-price model. But Guy Carpenter still grew 2% underlying in Q1 2026, which suggests the franchise is holding its ground.
The consulting side benefits from different demand drivers. Mercer is tied to health, wealth, and workforce needs, while Marsh Management Consulting is tied to strategic transformation and AI deployment. Doyle said Oliver Wyman’s AI Quotient team is the firm’s fastest-growing practice and has already advised on more than $50B of capital investment in AI deployment. That gives MRSH exposure to enterprise AI spending from the advisory side, which is often steadier than betting on whichever software vendor is fashionable this quarter.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
MRSH serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The customer base is broad, but the common thread is complexity. These are clients with enough risk, workforce, capital, or strategic exposure that they need more than a transactional broker.
The company’s scale in large accounts is visible in its own market data. Management said the Marsh Global Insurance Market Index skews toward large accounts, and that matters because large accounts tend to need deeper advisory support, more specialized placement, and more analytics. Those relationships are harder to dislodge than a simple small-business quote comparison.
Mercer’s customer profile adds another layer of stickiness. Employers use Mercer for health, wealth, and career advice, while institutions use its investment capabilities. With $727B of AUM and more than $16.2T of assets under advisement, Mercer is embedded in long-cycle decision making. That kind of relationship usually does not get replaced because a competitor offered a slightly prettier dashboard.
Institutional ownership of 95.14% also says something about the shareholder customer, so to speak. This is a stock heavily owned by large institutions, with Vanguard holding 46.6M shares and BlackRock holding 42.1M shares. That ownership base tends to favor consistency, capital discipline, and predictable compounding over dramatic strategic swings.
MRSH competes most directly with Aon, Willis Towers Watson, Arthur J. Gallagher, and Brown & Brown, along with direct insurers, consultants, banks, and other non-traditional providers. The company’s own materials also point to competition from third-party capital providers and online platforms. This is not an empty field. It is a crowded one with several well-armed incumbents.
What separates MRSH is breadth. It combines global retail brokerage, reinsurance, employee benefits, wealth advisory, and management consulting at a scale few peers can match. Industry context notes that MRSH reported 2024 revenue of $24.5B, with $15.4B in Risk & Insurance Services and $9.1B in Consulting. That diversification gives it more ways to win a client relationship and more ways to keep one.
The market is also shifting toward analytics-driven, portfolio-based broking rather than simple transactional placement. That plays to MRSH’s strengths. Management repeatedly emphasized proprietary data, modeling, claims advocacy, and AI-enabled tools. In a softer pricing market, the broker that can prove value beyond premium negotiation tends to defend margins better.
The main competitive risk is not that MRSH lacks scale. It is that peers are also consolidating, digitizing, and investing. In other words, this is a race where everyone has shoes. MRSH’s advantage is that it already has the client base, data assets, and capital base to keep running at the front.
MRSH sits at the intersection of several macro forces. Lower interest rates are a headwind to fiduciary interest income. In Q1 2026, fiduciary interest income was $85M, down $18M from the prior year, and management expects about $80M in Q2. That is a modest drag, but it is real.
Insurance pricing is another macro variable. Global commercial insurance rates declined 5% in Q1 2026, following a 4% decline in Q4 2025. Reinsurance pricing also softened, with some U.S. property catastrophe renewals down 15% to 20%. Those trends can reduce tailwinds that brokers enjoyed in harder markets.
At the same time, geopolitical tension can increase demand for MRSH’s advice. Doyle said the impact of the Middle East conflict on the company and the broader insurance industry had been limited, but he also said MRSH is helping clients navigate supply-chain issues, cyber exposure, marine, aviation, and energy risks, and investment decisions. Complex times are good for firms that sell complexity management.
The data center buildout is another macro tailwind with a cleaner growth profile. The investor presentation’s 103 GW to 200 GW global data center capacity forecast through 2030E gives MRSH a direct advisory and insurance angle on AI infrastructure spending. That is a useful offset to softer traditional insurance pricing because it ties the company to a structural capex theme rather than a cyclical pricing cycle.
Net debt was $18.76B at year-end 2025 and total debt reached $20.93B by March 31, 2026, leaving MRSH manageable but not cheap on leverage.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Revenue climbed to $26.98B in 2025 from $24.46B in 2024, while free cash flow rose to $5.00B and Q1 2026 adjusted EPS beat expectations at $3.29.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Q1 2026 revenue grew 8% and adjusted operating income also rose 8%, showing the business is still delivering even as insurance pricing softens.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →MRSH trades at 22.0x trailing earnings and 17.2x forward earnings with a PEG of 1.72, so the market is paying for quality rather than discounting risk.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The report’s fair value sits at $198, which supports a Buy view but leaves limited room for a dramatic rerating from current levels.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →MRSH is a serious business with serious advantages. It has scale in insurance broking and reinsurance, a valuable consulting arm, a strong record of margin expansion, and free cash flow that gives management real strategic flexibility. Q1 2026 reinforced that profile with 8% revenue growth, 8% adjusted operating income growth, and another EPS beat despite softer pricing and lower fiduciary interest income.
The investment case does not require heroics. It requires continued execution. If MRSH keeps converting scale, data, and AI tools into steady organic growth and operating leverage, the stock can continue compounding. The main limitation is valuation, not business quality. That is why the right stance is constructive but disciplined: Buy below the fair value estimate of $198, hold around it, and be wary of chasing the stock too far above it.
For moderate-risk investors, that is a good setup. MRSH is not flashy, but markets have a habit of rewarding companies that keep doing the hard things well. Quiet compounders rarely look dramatic in real time. They just keep showing up in portfolios that age better than the headlines.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
Marsh & McLennan Companies, Inc. (MRSH) gains after a steady Q1 that met expectations and reinforced the company’s resilience. This deep-dive earnings analysis examines margin durability, segment performance, guidance tone, and why investors rewarded disciplined execution over flash.
Marsh & McLennan stands out as a high-quality professional services compounder with strong margins, recurring fee-based revenue, and multiple growth levers. The stock looks more like a reasonable buy on weakness than a bargain-basement value play.
Marsh & McLennan Companies, Inc. (MRSH) gains 1.2% after earnings meets expectations, with investors reacting positively to the latest quarterly results.